GPT Healthcare FY26 PAT ₹42.2 Cr; Revenue Up 15.14% YoY
GPT Healthcare reported a 15.14% year-on-year increase in revenue to ₹478.5 Cr for FY26, while profit after tax fell by 15.43% to ₹42.2 Cr. For the fourth quarter, revenue grew 24.30% to ₹128.0 Cr. The Board recommended a total dividend of ₹2.50 per share, with the record date set for July 30, 2026.
*this image is generated using AI for illustrative purposes only.
GPT Healthcare Limited has announced that it participated in a conference call with investors on Tuesday, May 19, 2026, to discuss its audited financial results for the fourth quarter and financial year ended March 31, 2026. The call was held in compliance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that no unpublished price sensitive information was shared during the meeting. An audio recording of the discussion has been made available on the company's website.
Financial Performance Recap
The company had previously announced its financial results for the full year FY26. For the year ended March 31, 2026, GPT Healthcare reported a total income of ₹478.5 Cr, compared to ₹415.6 Cr in the previous year. Profit after tax (PAT) for the year stood at ₹42.2 Cr, a decrease of 15.43% from ₹49.9 Cr in FY25. Revenue from operations grew by 15.14% year-on-year to reach ₹478.5 Cr.
In the fourth quarter of FY26, revenue increased to ₹128.0 Cr from ₹103.0 Cr in the same period last year, representing a growth of 24.30%. Q4 net profit came in at ₹14.7 Cr versus ₹12.9 Cr year-on-year. The table below summarises the key financial metrics for the full year:
| Particulars (Rs. Crs) | FY26 | FY25 | Y-o-Y |
|---|---|---|---|
| Total Revenue | 478.5 | 415.6 | 15.14% |
| EBITDA | 90.1 | 91.8 | (1.86%) |
| EBITDA Margin (%) | 18.84% | 22.10% | |
| Profit After Tax | 42.2 | 49.9 | (15.43%) |
| PAT Margin (%) | 8.82% | 12.01% |
Operational Highlights
Operationally, the company maintained an ARPOB of INR 39,243 and recorded occupancy rates of 55.90%, excluding the newly commenced Raipur facility. Including the Raipur facility, the overall occupancy stood at 45.87%. The Raipur Hospital successfully commenced operations during the year. Additionally, the company launched Respiratory ICU and cardiac care services at ILS Dum Dum and installed robotic surgical technology in Salt Lake and Howrah Hospital, with over 800 robotic surgeries performed in Salt Lake. A Memorandum of Understanding (MoU) was also signed for a 150-bed facility in Jamshedpur, targeted for commissioning by the end of FY27.
Corporate Actions
The Board of Directors has recommended a final dividend of ₹1.50 per share for FY26, subject to shareholder approval. This includes an interim dividend of ₹1.00 per share already paid, bringing the total dividend for the year to ₹2.50 per equity share. The record date for determining dividend entitlement has been fixed as July 30, 2026. The 37th Annual General Meeting (AGM) is scheduled for August 6, 2026, via video conferencing.
Historical Stock Returns for GPT Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.65% | +0.04% | +3.26% | -2.33% | -10.21% | -29.29% |
How quickly will the Raipur facility's occupancy rates ramp up to match mature hospital levels, and what timeline is management targeting to reach breakeven at this location?
Will the planned 150-bed Jamshedpur facility under the Jamshedpur MoU be funded through internal accruals or external debt, and how might this impact GPT Healthcare's leverage ratios in FY27?
Given the significant compression in PAT margins from 12.01% to 8.82% despite strong revenue growth, what specific cost drivers are management prioritizing to restore profitability in FY27?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
